← Back to Search

Neurofeedback Training for Healthy Adults

N/A
Recruiting
Research Sponsored by Drexel University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be between 18 and 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up two sessions over one month
Awards & highlights

Study Summary

This trial will measure brain activity while participants do tasks to test attention. They'll get real-time feedback on their brain activity and try to control it.

Who is the study for?
This trial is for healthy adults aged 18-35 who have no history of psychiatric or neurological disorders and can safely undergo MRI scans. It's designed to understand how the brain works during different tasks by recording its activity.Check my eligibility
What is being tested?
The study tests if giving people real-time feedback on their brain activity helps them control it better. Participants will first have their brain activity measured while doing attention tasks, then try to modify that activity in a second session using neurofeedback.See study design
What are the potential side effects?
Since this trial involves non-invasive techniques like EEG and fMRI, side effects are minimal but may include discomfort from wearing the EEG cap or staying still in the MRI scanner for long periods.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~two sessions over one month
This trial's timeline: 3 weeks for screening, Varies for treatment, and two sessions over one month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Number of participants with EEG measurements that are predictive of the default mode network brain activity measured with fMRI

Trial Design

1Treatment groups
Experimental Treatment
Group I: NeurofeedbackExperimental Treatment1 Intervention
Subjects will undergo one session where they will visualize real-time feedback of signals recorded from their brains.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Neurofeedback
2019
Completed Phase 3
~1030

Find a Location

Who is running the clinical trial?

Drexel UniversityLead Sponsor
150 Previous Clinical Trials
47,677 Total Patients Enrolled
National Institute of Mental Health (NIMH)NIH
2,786 Previous Clinical Trials
2,689,743 Total Patients Enrolled

Media Library

Neurofeedback Clinical Trial Eligibility Overview. Trial Name: NCT05592600 — N/A
Healthy Subjects Research Study Groups: Neurofeedback
Healthy Subjects Clinical Trial 2023: Neurofeedback Highlights & Side Effects. Trial Name: NCT05592600 — N/A
Neurofeedback 2023 Treatment Timeline for Medical Study. Trial Name: NCT05592600 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this test group limited to people under 40 years of age?

"This clinical trial is looking for young adults aged between 18 to 35. Separately, 50 studies are recruiting minors and 372 seniors have been recruited into other trials."

Answered by AI

Are there any slots open for volunteer subjects in this trial?

"According to the clinicaltrials.gov database, this medical research is no longer recruiting participants. The first posting was on October 1st 2022 and the last update took place on October 21st 2022. However, 845 other studies remain active in seeking enrolment at this time."

Answered by AI

Could I participate in this experiment?

"This medical experiment is searching for 24 volunteers aged between 18 and 35 who are characterised as healthy subjects (hs). The required criteria to be met in order to qualify include being within the specified age range."

Answered by AI

Who else is applying?

What state do they live in?
New Jersey
What portion of applicants met pre-screening criteria?
Met criteria
What site did they apply to?
Temple University Brain Research and Imaging Center

Why did patients apply to this trial?

Interested in a study with healthy volunteers.
PatientReceived 2+ prior treatments
~16 spots leftby Apr 2025